Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jul 30;106(8):dju186.
doi: 10.1093/jnci/dju186. Print 2014 Aug.

Developing interventions for cancer-related cognitive dysfunction in childhood cancer survivors

Sharon M Castellino  1 , Nicole J Ullrich  2 , Megan J Whelen  2 , Beverly J Lange  2
Affiliations
Review

Developing interventions for cancer-related cognitive dysfunction in childhood cancer survivors

Sharon M Castellino et al. J Natl Cancer Inst. .

Abstract

Survivors of childhood cancer frequently experience cancer-related cognitive dysfunction, commonly months to years after treatment for pediatric brain tumors, acute lymphoblastic leukemia (ALL), or tumors involving the head and neck. Risk factors for cancer-related cognitive dysfunction include young age at diagnosis, treatment with cranial irradiation, use of parenteral or intrathecal methotrexate, female sex, and pre-existing comorbidities. Limiting use and reducing doses and volume of cranial irradiation while intensifying chemotherapy have improved survival and reduced the severity of cognitive dysfunction, especially in leukemia. Nonetheless, problems in core functional domains of attention, processing speed, working memory and visual-motor integration continue to compromise quality of life and performance. We review the epidemiology, pathophysiology and assessment of cancer-related cognitive dysfunction, the impact of treatment changes for prevention, and the broad strategies for educational and pharmacological interventions to remediate established cognitive dysfunction following childhood cancer. The increased years of life saved after childhood cancer warrants continued study toward the prevention and remediation of cancer-related cognitive dysfunction, using uniform assessments anchored in functional outcomes.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Factors contributing to risk of cancer-related cognitive dysfunction in childhood cancer survivors. Risk of impairment varies by timing of assessment relative to diagnosis and treatment, and by the assessment battery used. CNS = central nervous system.
Figure 2.
Figure 2.
Conceptual approach to design of future interventions for protection and remediation against cancer-related cognitive dysfunction.
See this image and copyright information in PMC

References

    1. Conklin HM, Khan RB, Reddick WE, et al. Acute neurocognitive response to methylphenidate among survivors of childhood cancer: a randomized, double-blind, cross-over trial. J Pediatr Psychol. 2007;32(9):1127–1139. - PubMed
    1. Robinson KE, Livesay KL, Campbell LK, et al. Working memory in survivors of childhood acute lymphocytic leukemia: functional neuroimaging analyses. Pediatr Blood Cancer. 2010;54(4):585–590. - PMC - PubMed
    1. Mulhern RK, Butler RW. Neurocognitive sequelae of childhood cancers and their treatment. Pediatr Rehabil. 2004;7(1):1–14; discussion 15–16. - PubMed
    1. Duffner PK. Risk factors for cognitive decline in children treated for brain tumors. Eur J Paediatr Neurol. 2010;14(2):106–115. - PubMed
    1. Glauser TA, Packer RJ. Cognitive deficits in long-term survivors of childhood brain tumors. Childs Nerv Syst. 1991;7(1):2–12. - PubMed

Publication types

MeSH terms